🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesHas anyone dealt with anti-thrombotic properties of glp-1 receptor activation? Page 4

Has anyone dealt with anti-thrombotic properties of glp-1 receptor activation?

rachel_ABQ Tue, Nov 18, 2025 at 5:17 PM 30 replies 1,490 viewsPage 4 of 6
pat_auckland
Member
345
1,567
Jun 2024
Auckland, NZ
Nov 25, 2025 at 11:44 PM#16

Adding the clinical framing, because it changes how the question reads. The version of this that has an answer is narrower than the version being asked. Narrow it and it becomes tractable; leave it broad and the thread will produce nine confident and incompatible replies.

Correct me if the detail matters more than I have assumed.

13 13NurseAsh_DET, BenResearch_OR, MikeKY_noInsulin and 10 others
Reply Quote Save Share Report
LeilaHI
Member
167
789
Jan 2025
Honolulu, HI
Nov 27, 2025 at 1:31 AM#17
anders_CPH said:
Keep the original post as written when you update it, and add the correction underneath.

True, and it depends on a baseline nobody has stated. Without knowing where someone started, the same number can be an excellent result or a disappointing one.

12 12VendorMark, COA_Karl, MikeFit_NJ and 9 others
Reply Quote Save Share Report
mia_MS2
New Member
8
23
Jun 2026
Ann Arbor, MI
Nov 28, 2025 at 3:18 AM#18
anders_CPH said:
Keep the original post as written when you update it, and add the correction underneath.

This is exactly what I could not find anywhere else. I will report back once I have actually tried it.

11 11dave_SLC, FDA_TrackerJim, ricardo_MIA and 8 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
claudia_zurich
Member
389
1,678
Jul 2024
Zurich, CH
Nov 29, 2025 at 5:04 AM#19

Clinical perspective, offered as context rather than as advice. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

10 10alex_tucson, kevin_tulsa, Dr.PainCLE and 7 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Nov 30, 2025 at 6:50 AM#20

Moderator note: a post naming a supplier has been edited. Discuss suppliers in the review sections, not here.

38 13PurityPaulOR, MaxMetOK, MounjBrad and 35 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register